Table 3 Mutations validation.

From: Insight into molecular and mutational scrutiny of epilepsy associated gene Gabrg2 leading to novel computer-aided drug designing

Serial No

nsSNPs

SIFT

Polyphene-2

Provean

SNAP2

I-Mutant

MUpro

1

V29Y

Deleterious (< 0.05)

Unknown

Disease

Effect protein structure (score = 61)

Decrease

Decrease (− 1.33)

2

S30E

Deleterious (< 0.05)

Benign (0.001)

Disease

Effect protein structure (score = 54)

Decrease

Decrease (− 0.74)

3

F31Y

Deleterious (< 0.05)

Benign (0.002)

Disease

Effect protein structure

(score = 25)

Decrease

Decrease (− 1.24)

4

Q32T

Deleterious (< 0.05)

Benign (0.009)

Disease

Effect protein structure

(score = 15)

Decrease

Decrease (− 0.88)

5

K34D

Deleterious (< 0.05)

Benign (0.000)

Disease

Effect protein structure

(score = 50)

Decrease

Decrease (− 0.58)

6

F36I

Deleterious (< 0.05)

Possibly damaging (0.824)

Disease

Effect protein structure

(score = 52)

Decrease

Decrease (− 0.9)

  1. 1 Tables may have a footer.